Penson, P, Ford, WR and Broadley, KJ (2007) Vasopressors for cardiopulmonary resuscitation. Does pharmacological evidence support clinical practice? Pharmacology and Therapeutics, 115 (1). pp. 37-55. ISSN 0163-7258

Preview

Text Vasopressors for cardiopulmonary resuscitation Penson Ford and Broadley[1].pdf - Accepted Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (582kB) | Preview

Abstract

Adrenaline (epinephrine) has been used for cardiopulmonary resuscitation (CPR) since 1896. The rationale behind its use is thought to be its alpha-adrenoceptor-mediated peripheral vasoconstriction, causing residual blood flow to be diverted to coronary and cerebral circulations. This protects these tissues from ischaemic damage and increases the likelihood of restoration of spontaneous circulation. Clinical trials have not demonstrated any benefit of adrenaline over placebo as an agent for resuscitation. Adrenaline has deleterious effects in the setting of resuscitation, predictable from its promiscuous pharmacological profile. This article discusses the relevant pharmacology of adrenaline in the context of CPR. Experimental and clinical evidences for the use of adrenaline and alternative vasopressor agents in resuscitation are given, and the properties of an ideal vasopressor are discussed.

Item Type:	Article
Uncontrolled Keywords:	1115 Pharmacology And Pharmaceutical Sciences
Subjects:	R Medicine > RM Therapeutics. Pharmacology R Medicine > RS Pharmacy and materia medica
Divisions:	Pharmacy & Biomolecular Sciences
Publisher:	Elsevier
Related URLs:	Author
Date Deposited:	27 Apr 2016 10:38
Last Modified:	20 Apr 2022 09:10
DOI or ID number:	10.1016/j.pharmthera.2007.03.003
URI:	https://researchonline.ljmu.ac.uk/id/eprint/3530

View Item